1262794-03-5

Basic information

• Product Name: 7-methoxy-3-(3,5-di-(3-methylmaleimido)benzyl)aminocarbonyl coumarin
• Synonyms: 7-methoxy-3-(3,5-di-(3-methylmaleimido)benzyl)aminocarbonyl coumarin
• CAS NO: 1262794-03-5
• Molecular Weight: 527.49
• Mol File: 1262794-03-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 7-methoxy-3-(3,5-di-(3-methylmaleimido)benzyl)aminocarbonyl coumarin(CAS DataBase Reference)
• NIST Chemistry Reference: 7-methoxy-3-(3,5-di-(3-methylmaleimido)benzyl)aminocarbonyl coumarin(1262794-03-5)
• EPA Substance Registry System: 7-methoxy-3-(3,5-di-(3-methylmaleimido)benzyl)aminocarbonyl coumarin(1262794-03-5)

Safety Data

• Hazardous Substances Data: 1262794-03-5(Hazardous Substances Data)

Upstream product

• 673-22-3 2-Hydroxy-4-methoxybenzaldehyde 
• 444343-45-7 N-(3,5-dinitrobenzyl)phthalimide 
• 1262794-02-4 7-methoxy-3-(3,5-dinitrobenzyl)aminocarbonylcoumarin 
• 771579-30-7 3,5-dinitrobenzylamine 
• 99-34-3 3,5-dinitrobenzoic acid 
• 71022-43-0 3,5-dinitrobenzyl alcohol 
• 20300-59-8 7-methoxycoumarin-3-carboxylic acid 
• 616-02-4 citraconic acid anhydride 
• 1262794-01-3 tert-butyl N-3,5-dinitrobenzylcarbamate 

Relevant articles and documents

Fluorescent markers and use thereof for labeling specific protein targets

Novel fluorescent markers of Formula I: are disclosed herein, wherein X and Y are independently or together absent or are independently selected from R and R1 are independently selected from H and alkyl; Ar is phenyl or heteroaryl; L is absent or a spacer selected from the group consisting of —NH—; —(CH2)nNH—; —NHSO2—; —(CH2)nNHCO—; -(cycloalkyl)NHCO—; —(CH2)nNHSO2—; -(cycloalkyl)NHSO2—; —CONH(CH2)nNHCO—; —CONH(cycloalkyl)NHCO—; —NHCO(CH2)nNHCO—; —NHCO(cycloalkyl)NHCO—; —(CH2)nSO2NH—; -(cycloalkyl)SO2NH—; —(CH2)nNHCSNH—; -(cycloalkyl)NHCSNH—; —CR═CR1—; —C≡C—; —(CH2)nN═CH—; -(cycloalkyl)N═CH—; —N═CH(CH2)—; —N═CH(cycloalkyl)-; n is an integer ranging from 1 to 5; F is a fluorophore selected from the group consisting of fluorescein, rhodamine, eosin, thionine, safranin, coumarin, methoxycoumarin, dansyl, BODIPY and BODIPY derivatives; and wherein X, Y and L may be positioned in a 1,3,5; 1,2,3; 1,3,4 or in a 3,4,5 configuration respectively.